• Home
  • 公开发售

Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company

biondvax pharmaceuticals

Represents first Israeli-American collaborative transaction between affiliated law firms SRFF LLP and DTKGC & Co.

New York, NY – May 15, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the underwriter Aegis Capital Corp. on the U.S. initial public offering of BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV), an Israeli biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infection diseases. The public offering involved the sale of 1,910,000 American Depositary Shares (ADSs), with each ADS representing 40 of its ordinary shares, and warrants to purchase 1,910,000 ADSs (excluding over-allotment option) at an offering price of $5.00 per ADS and $0.01 per warrant. Biondvax raised approximately $9,550,000 in gross proceeds.

This is the first collaborative transaction completed between SRFF and its new affiliate Israeli law firm, Doron, Tikotzky, Kantor, Gutman, Cederboum & Co. (“DTKGC”). DTKGC’s partner Ronen Kantor led the Israeli team and represented Aegis Capital Corp. as the underwriter in Israel and SRFF’s partner Gregory Sichenzia and Associate Gary Emmanuel advised Aegis Capital Corp. as underwriter in the U.S.  SRFF and DTKGC launched an affiliate partnership earlier this month to provide their Israeli and American clients the ability to seamlessly conduct public offerings in the U.S. and Israeli capital markets.

About Sichenzia Ross Friedman Ference LLP

Sichenzia Ross Friedman Ference LLP is law firm based in New York City that provides experienced representation in all matters involving the securities industry. Their attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative publication offerings, preparation of SEC filings and listing to major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, the Firm’s litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other regulatory agencies. SRFF has international affiliations in Europe and also specializes in advising foreign issuers in U.S. IPOs and public offerings. To learn more, visit www.srff.com and follow SRFF on twitter @srffllp


About Doron, Tikotzky, Kantor, Gutman, Cederboum & Co.

DTKCG is an Israeli law firm that was recently formed after Doron, Tkotzky, Cederboum merged with Kantor & Co. Law Offices. DTKGC’s attorneys specialize in the areas of litigation, tax law,  real estate, labor and unemployment law, securities law, Israeli and U.S. capital markets, corporate finance and venture capital, private equity investments, intellectual property, estate planning, mergers and acquisitions, biotechnology, bankruptcy and banking. To learn more about DTKGC & Co., please visit: www.dtkgc.om